Revolution Medicines Form 144 lists insider resale details

Revolution Medicines: Form 144 notice of proposed resale of Common Stock by an affiliate.

Rhea-AI Filing Summary

Revolution Medicines: Form 144 notice of proposed resale of Common Stock by an affiliate. The filing lists past sales by Jeff Cislini of $206,483.83 for 2,688 shares on 12/16/2025 and $104,964.80 for 908 shares on 01/21/2026. The record also lists historic restricted stock unit grants of 219, 222, 548, 521, and 543 shares on various grant dates; these grant counts are shown as award history.

Insights

Securities Compliance Analyst

Form 144 lists proposed reseller activity and prior open-market sales by the reporting person.

The filing records two recent sales by Jeff Cislini: 2,688 shares for $206,483.83 on 12/16/2025 and 908 shares for $104,964.80 on 01/21/2026

Grant history shows multiple restricted stock unit awards across 2022–2025 with discrete share counts; timing and amounts for any proposed resale are the central compliance signals. Cash‑flow treatment for future sales is not stated in the excerpt.

Equity Transactions Specialist

Reported past transactions provide a position and sale history but do not itself indicate planned volume or timing.

The filing itemizes prior RSU grants (dates and share counts) which establish source of shares for potential resale. The two disclosed sales include exact proceeds, making them traceable transactions.

Further filings would be needed to confirm any new proposed resale amounts or distribution methods.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Revolution Medicines (RVMD) Form 144 show about recent insider sales?

The Form 144 lists two recent sales by Jeff Cislini: 2,688 shares for $206,483.83 on 12/16/2025 and 908 shares for $104,964.80 on 01/21/2026. These entries record proceeds and share counts for those sales.

Does the Form 144 indicate how many shares are proposed for resale by the filer (RVMD)?

The excerpt provides past sale transactions and RSU grant history but does not state an explicit aggregate amount being registered for resale. The filing shows historic grant counts and two completed sales with proceeds and dates.

What RSU grant history is shown for the reporting person in the RVMD filing?

The filing lists restricted stock unit grants on multiple dates: 219, 222, 548, 521, and 543 shares across 2022–2025. Each entry is labeled as a services‑rendered grant with its grant date.

Who received proceeds from the reported transactions in the RVMD Form 144?

The filing provides sale proceeds amounts ($206,483.83 and $104,964.80) tied to the two disclosed open‑market sales by Jeff Cislini; it does not state any alternate recipient or use of proceeds beyond those transaction entries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 07:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001969082
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 SAGINAW DR REDWOOD CITY CALIFORNIA 94063
Phone	650-481-6801
Name of Person for Whose Account the Securities are To Be Sold	Cislini Jeff
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	2053	204458.27	198173397	03/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2022	Restricted stock unit grant	Issuer			219	03/01/2022	Services rendered
Common Stock	09/01/2022	Restricted stock unit grant	Issuer			222	09/01/2022	Services rendered
Common Stock	03/01/2023	Restricted stock unit grant	Issuer			548	03/01/2023	Services rendered
Common Stock	03/01/2024	Restricted stock unit grant	Issuer			521	03/01/2024	Services rendered
Common Stock	03/01/2025	Restricted stock unit grant	Issuer			543	03/01/2025	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeff Cislini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	12/16/2025	2688	206483.83
Jeff Cislini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	01/21/2026	908	104964.80

144: Remarks and Signature

Remarks
Date of Notice	03/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/31/2023
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jack Anders, as Attorney-in-fact for Jeff Cislini
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)